CATHAY INTERNATIONAL HOLDINGS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.75 GBX | -25.00% |
|
-.--% | -78.57% |
Financials (USD)
| Sales 2018 | 84.3M | Sales 2019 | 79.76M | Capitalization | 13.23M |
|---|---|---|---|---|---|
| Net income 2018 | -18M | Net income 2019 | -20M | EV / Sales 2018 | 2.53 x |
| Net Debt 2018 | 185M | Net Debt 2019 | 168M | EV / Sales 2019 | 2.27 x |
| P/E ratio 2018 |
-1.52
x | P/E ratio 2019 |
-0.66
x | Employees | - |
| Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 26.49% |
More Fundamentals
* Assessed data
More news
| 1 day | -25.00% |
CATHAY INTERNATIONAL HOLDINGS LIMITED is an investment holding company principally engaged in the healthcare business. The Company operates five business segments through its subsidiaries. The Lansen segment engages in the manufacture and sale of pharmaceuticals, cosmeceutical products and plant extracts and healthcare products. The Haizi segment produces inositol and its by-product, di-calcium phosphate. The Natural Dailyhealth segment is involved in the production and sales of plant extracts for use as active ingredients in health products. The Botai segment involves in the production and sales of collagen injectable fillers and development of collagen related products. The Hotel Operation segment operates a hotel.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -78.57% | 54.86M | |
| +28.79% | 677B | |
| +25.94% | 560B | |
| -5.84% | 355B | |
| +15.75% | 319B | |
| +4.32% | 287B | |
| +4.00% | 214B | |
| +1.92% | 207B | |
| -7.93% | 199B | |
| -10.00% | 146B |
- Stock Market
- Equities
- CTI Stock
